SymbNET – Genomics and Metabolomics in a Host-Microbe Symbiosis Network 

SymbNET is a European network for research on host-microbe symbiosis, funded by the European Union’s Horizon 2020 research and innovation programme. Animals and plants live with microbial communities that have a strong impact on their development, physiology, and evolution. Thus, understanding these symbiotic interactions is a crucial axis of research in Fundamental Biology and Health Sciences. This field requires multidisciplinary, highly skilled teams and collaborative research.

SymbNET will create a European network in the use of Genomics and Metabolomics in Host-Microbe Symbiosis research. It will bring together a consortium of leaders in the field that present a wide range of expertise, technological knowledge, scientific questions and approaches in Host-Microbe Symbiosis. SymbNET will promote the transfer of knowledge and collaborations through programs of Researchers and Staff visit exchanges, collaborative projects, sponsoring the use of new technologies, organizing scientific meetings, workshops, PhD Summer Schools, and a European meeting on Host-Microbe Symbiosis. There will be specific actions targeted at Early Stage Researchers to promote their research, training, mentoring, and networking, ensuring gender equality in participation.

SymbNET will establish a European consortium in Host-Microbe Symbiosis, capacitate the participating institutions, and promote this crucial growing area of research at the local and international level.

The project coordinated by FCG-IGC (Instituto Gulbenkian de Ciência, Portugal), brings together another local partner ITQB NOVA (Instituto de Tecnologia Química e Biológica, Portugal) and the European research institutions EMBL (European Molecular Biology Laboratory, Germany)CAU (Christian-Albrechts-Universität zu Kiel, Germany),  and UNIL (Université de Lausanne,  Switzerland).



This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952537.

Updated on 23 october 2023